Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
In terms of region, the global ophthalmic anti-infective market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global ophthalmic anti-infective market due to availability of advanced drug formulations in the region. Awareness among people about diseases is also a major factor boosting the market in the region. The ophthalmic anti-infective market in Asia Pacific is anticipated to expand at a rapid pace due to increase in incidence of eye infection in the region. Lack of awareness about diseases and unavailability of advanced medication and formulations in underdeveloped countries, such as Lebanon, Syria, Cyprus, Turkey, and Iraq are likely to restrain the growth of the ophthalmic anti-infective market in Middle East & Africa.
The report details the trend, potential and market size of Anti-infective Ophthalmic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-infective Ophthalmicmarket, defines the market attractiveness level of Anti-infective Ophthalmic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-infective Ophthalmic industry, describes the types of Anti-infective Ophthalmic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-infective Ophthalmic market and the development prospects and opportunities of Anti-infective Ophthalmic industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-infective Ophthalmic market in Chapter 13.
By Player:
Lupin Pharmaceuticals
Valeant Pharmaceuticals
Akorn
Santen Pharmaceutical
Novartis
Allergan
Apotex
By Type:
Antibacterial
Antiviral
Antifungal
Anti-parasitic
Others
By End-User:
Hospital Use
Clinic Use
Household
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-infective Ophthalmic Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-infective Ophthalmic Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-infective Ophthalmic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-infective Ophthalmic Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-infective Ophthalmic Market Analysis and Outlook to 2022
-
7.1 Global Anti-infective Ophthalmic Consumption (2017-2022)
-
7.2 United States Anti-infective Ophthalmic Consumption (2017-2022)
-
7.3 Europe Anti-infective Ophthalmic Consumption (2017-2022)
-
7.4 China Anti-infective Ophthalmic Consumption (2017-2022)
-
7.5 Japan Anti-infective Ophthalmic Consumption (2017-2022)
-
7.6 India Anti-infective Ophthalmic Consumption (2017-2022)
-
7.7 South Korea Anti-infective Ophthalmic Consumption (2017-2022)
8 Region and Country-wise Anti-infective Ophthalmic Market Analysis and Outlook to 2028
-
8.1 Global Anti-infective Ophthalmic Consumption Forecast (2022-2028)
-
8.2 United States Anti-infective Ophthalmic Consumption Forecast (2022-2028)
-
8.3 Europe Anti-infective Ophthalmic Consumption Forecast (2022-2028)
-
8.4 China Anti-infective Ophthalmic Consumption Forecast (2022-2028)
-
8.5 Japan Anti-infective Ophthalmic Consumption Forecast (2022-2028)
-
8.6 India Anti-infective Ophthalmic Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-infective Ophthalmic Consumption Forecast (2022-2028)
9 Global Anti-infective Ophthalmic Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-infective Ophthalmic Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antibacterial Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antiviral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Antifungal Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Anti-parasitic Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-infective Ophthalmic Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Use Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Use Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Household Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Anti-infective Ophthalmic Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-infective Ophthalmic Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antibacterial Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antiviral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Antifungal Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Anti-parasitic Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-infective Ophthalmic Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Use Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Household Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-infective Ophthalmic Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-infective Ophthalmic Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-infective Ophthalmic Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-infective Ophthalmic Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-infective Ophthalmic Market Competitive Analysis
-
14.1 Lupin Pharmaceuticals
-
14.1.1 Lupin Pharmaceuticals Company Details
-
14.1.2 Lupin Pharmaceuticals Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Lupin Pharmaceuticals Anti-infective Ophthalmic Product and Service
-
14.2 Valeant Pharmaceuticals
-
14.2.1 Valeant Pharmaceuticals Company Details
-
14.2.2 Valeant Pharmaceuticals Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Valeant Pharmaceuticals Anti-infective Ophthalmic Product and Service
-
14.3 Akorn
-
14.3.1 Akorn Company Details
-
14.3.2 Akorn Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Akorn Anti-infective Ophthalmic Product and Service
-
14.4 Santen Pharmaceutical
-
14.4.1 Santen Pharmaceutical Company Details
-
14.4.2 Santen Pharmaceutical Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Santen Pharmaceutical Anti-infective Ophthalmic Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Anti-infective Ophthalmic Product and Service
-
14.6 Allergan
-
14.6.1 Allergan Company Details
-
14.6.2 Allergan Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Allergan Anti-infective Ophthalmic Product and Service
-
14.7 Apotex
-
14.7.1 Apotex Company Details
-
14.7.2 Apotex Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Apotex Anti-infective Ophthalmic Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-infective Ophthalmic
-
Figure Anti-infective Ophthalmic Picture
-
Table Global Anti-infective Ophthalmic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-infective Ophthalmic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-infective Ophthalmic Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-infective Ophthalmic Consumption by Country (2017-2022)
-
Figure United States Anti-infective Ophthalmic Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-infective Ophthalmic Consumption and Growth Rate (2017-2022)
-
Figure China Anti-infective Ophthalmic Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-infective Ophthalmic Consumption and Growth Rate (2017-2022)
-
Figure India Anti-infective Ophthalmic Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-infective Ophthalmic Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-infective Ophthalmic Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-infective Ophthalmic Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-infective Ophthalmic Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-infective Ophthalmic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-infective Ophthalmic Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-infective Ophthalmic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-infective Ophthalmic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibacterial Consumption and Growth Rate (2017-2022)
-
Figure Global Antiviral Consumption and Growth Rate (2017-2022)
-
Figure Global Antifungal Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-parasitic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Use Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Use Consumption and Growth Rate (2017-2022)
-
Figure Global Household Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Antibacterial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiviral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antifungal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-parasitic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Household Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-infective Ophthalmic Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-infective Ophthalmic Export by Region (Top 5 Countries) (2017-2028)
-
Table Lupin Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Lupin Pharmaceuticals Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Pharmaceuticals Anti-infective Ophthalmic Product and Service
-
Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceuticals Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals Anti-infective Ophthalmic Product and Service
-
Table Akorn (Foundation Year, Company Profile and etc.)
-
Table Akorn Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akorn Anti-infective Ophthalmic Product and Service
-
Table Santen Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Santen Pharmaceutical Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Santen Pharmaceutical Anti-infective Ophthalmic Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Anti-infective Ophthalmic Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Anti-infective Ophthalmic Product and Service
-
Table Apotex (Foundation Year, Company Profile and etc.)
-
Table Apotex Anti-infective Ophthalmic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Anti-infective Ophthalmic Product and Service
-
